A Specific Inhibitor of Complement (C5)-Derived Chemotactic Activity in Serum from Patients with Systemic Lupus Erythematosus

In the course of examining polymorphonuclear leukocyte (PMN) chemotaxis in patients with systemic lupus erythematosus (SLE), we have found a previously undescribed serum inhibitor of complement (C5)-derived chemotactic activity. Serum from a 25-yr-old Black female with untreated SLE, when activated...

Olles dieđut

Bibliográfalaš dieđut

Publikašuvnnas:	J Clin Invest
Váldodahkkit:	Perez, H. Daniel, Lipton, Mark, Goldstein, Ira M.
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	American Society for Clinical Investigation 1978
Fáttát:	Articles
Liŋkkat:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC371733/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/659635/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI109110
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!